Alpha 2.0
Login Register
» Articles » PMID: 39073583

Terlipressin Use in HRS-AKI and Respiratory Failure

Overview
Journal Intensive Care Med
Specialty Critical Care
Date 2024 Jul 29
PMID 39073583
Authors
Romain Arrestier
Pierre-Antoine Billiet
Thomas Frapard
Armand Mekontso Dessap
Affiliations
Soon will be listed here.
Citing Articles

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis.

Wong F, Pappas S Intensive Care Med. 2024; 51(1):213-214.

PMID: 39441357 DOI: 10.1007/s00134-024-07681-4.

Terlipressin use in HRS-AKI and respiratory failure. Author's reply.

Nadim M, Forni L, Ostermann M Intensive Care Med. 2024; 50(10):1713-1714.

PMID: 39133282 DOI: 10.1007/s00134-024-07585-3.

References
1.
Nadim M, Forni L, Ostermann M . Terlipressin use in HRS-AKI and respiratory failure. Author's reply. Intensive Care Med. 2024; 50(10):1713-1714. DOI: 10.1007/s00134-024-07585-3. View
2.
Wong F, Pappas S, Curry M, Reddy K, Rubin R, Porayko M . Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome. N Engl J Med. 2021; 384(9):818-828. DOI: 10.1056/NEJMoa2008290. View
3.
Wong F, Pappas S, Reddy K, Vargas H, Curry M, Sanyal A . Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther. 2022; 56(8):1284-1293. PMC: 9804971. DOI: 10.1111/apt.17195. View
4.
Cavallin M, Piano S, Romano A, Fasolato S, Frigo A, Benetti G . Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study. Hepatology. 2015; 63(3):983-92. DOI: 10.1002/hep.28396. View
5.
Curry M, Vargas H, Befeler A, Pyrsopoulos N, Patwardhan V, Jamil K . Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatol Commun. 2023; 7(1):e1307. PMC: 9827960. DOI: 10.1097/01.HC9.0000897228.91307.0c. View